GBI Research has released its
pharma report "Systemic Psoriasis Therapeutics in Major Developed Markets
to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive
Growth". The systemic psoriasis market is forecast to grow substantially
over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020,
across the eight major markets. This growth will be driven by a rising
treatment population and the continued uptake of biologics.
Read
Complete Report with TOC @ http://www.radiantinsights.com/research/systemic-psoriasis-therapeutics-in-major-developed-markets-to-2020-continued-uptake-of-biologics-and-novel-pipeline-drugs-to-drive-growth
Biologics will continue to drive
market growth despite leading brands Enbrel (etanercept), Humira (adalimumab)
and Remicade (infliximab) losing patent protection in most of the major markets
over the forecast period. Although the market will suffer revenue losses as a
result of sales erosion from biosimilar competitors, this will be offset by the
emergence of novel therapies. Most notably, these include monoclonal antibodies
secukinumab, ixekizumab and brodalumab, which are currently being developed by
Alcon (Novartis subsidiary), Eli Lilly and Amgen, respectively.
Scope
- An introduction to psoriasis,
which includes symptoms, epidemiology, etiology, pathophysiology, diagnosis and
treatment
- Analysis of the major systemic
therapies in the current psoriasis marketed landscape
-
Analysis of the pipeline for psoriasis, which includes a breakdown of pipeline
molecules by phase of development, molecule type, molecular target and novelty.
Psoriasis clinical trials are analyzed by size, duration and failure rates, and
a comparative analysis of the most promising systemic pipeline molecules is
also provided.
About Radiant
Insights
Radiant
Insights is a platform for companies looking to meet their market research and
business intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For More
Information, Visit Radiant
Insights
Contact:
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
Phone:
1-415-349-0054
Toll
Free: 1-888-202-9519
Email:
sales@radiantinsights.com
Blog
URL: http://radiantinsights.weebly.com/
No comments:
Post a Comment